These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Elevated serum uric acid predicts angiographic impaired reperfusion and 1-year mortality in ST-segment elevation myocardial infarction patients undergoing percutaneous coronary intervention. Basar N; Sen N; Ozcan F; Erden G; Kanat S; Sokmen E; Isleyen A; Yuzgecer H; Ozlu MF; Yildirimkaya M; Maden O; Covic A; Johnson RJ; Kanbay M J Investig Med; 2011 Aug; 59(6):931-7. PubMed ID: 21415772 [TBL] [Abstract][Full Text] [Related]
4. Relationship between TIMI frame count and admission glucose values in acute ST elevation myocardial infarction patients who underwent successful primary percutaneous intervention. Ege M; Güray U; Güray Y; Yılmaz MB; Demirkan B; Saşmaz A; Korkmaz S Anadolu Kardiyol Derg; 2011 May; 11(3):213-7. PubMed ID: 21421510 [TBL] [Abstract][Full Text] [Related]
5. Plasma B-type natriuretic peptide level can predict myocardial tissue perfusion in patients undergoing primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction. Seo SM; Kim S; Chang K; Min J; Kim TH; Koh YS; Park HJ; Shin WS; Lee JM; Kim PJ; Chung WS; Seung KB Coron Artery Dis; 2011; 22(6):405-10. PubMed ID: 21701385 [TBL] [Abstract][Full Text] [Related]
6. Predictive value of admission red cell distribution width-platelet ratio for no-reflow phenomenon in acute ST segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Celık T; Balta S; Demır M; Yıldırım AO; Kaya MG; Ozturk C; Demırkol S; Unlu M; Kılıc S; Aydın İ; Iyısoy A Cardiol J; 2016; 23(1):84-92. PubMed ID: 26503078 [TBL] [Abstract][Full Text] [Related]
7. [Correlation of serum uric acid levels with coronary flow in patients with ST-segment elevation myocardial infarction undergoing primary coronary intervention]. Wang JW; Chen YD; Wang CH; Zhu XL Zhonghua Yi Xue Za Zhi; 2012 Nov; 92(44):3100-3. PubMed ID: 23328417 [TBL] [Abstract][Full Text] [Related]
9. Reduced-dose fibrinolytic acceleration of ST-segment elevation myocardial infarction treatment coupled with urgent percutaneous coronary intervention compared to primary percutaneous coronary intervention alone results of the AMICO (Alliance for Myocardial Infarction Care Optimization) Registry. Denktas AE; Athar H; Henry TD; Larson DM; Simons M; Chan RS; Niles NW; Thiele H; Schuler G; Ahn C; Sdringola S; Anderson HV; McKay RG; Smalling RW JACC Cardiovasc Interv; 2008 Oct; 1(5):504-10. PubMed ID: 19463352 [TBL] [Abstract][Full Text] [Related]
10. Impact of admission glomerular filtration rate on the development of poor myocardial perfusion after primary percutaneous intervention in patients with acute myocardial infarction. Celik T; Iyisoy A; Yuksel CU; Kilic S; Yilmaz MI; Akgul EO; Jata B; Isik E Coron Artery Dis; 2008 Dec; 19(8):543-9. PubMed ID: 19005288 [TBL] [Abstract][Full Text] [Related]
11. Randomized comparison of pre-hospital-initiated facilitated percutaneous coronary intervention versus primary percutaneous coronary intervention in acute myocardial infarction very early after symptom onset: the LIPSIA-STEMI trial (Leipzig immediate prehospital facilitated angioplasty in ST-segment myocardial infarction). Thiele H; Eitel I; Meinberg C; Desch S; Leuschner A; Pfeiffer D; Hartmann A; Lotze U; Strauss W; Schuler G; JACC Cardiovasc Interv; 2011 Jun; 4(6):605-14. PubMed ID: 21700245 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of high-dose atorvastatin loading before primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: the STATIN STEMI trial. Kim JS; Kim J; Choi D; Lee CJ; Lee SH; Ko YG; Hong MK; Kim BK; Oh SJ; Jeon DW; Yang JY; Cho JR; Lee NH; Cho YH; Cho DK; Jang Y JACC Cardiovasc Interv; 2010 Mar; 3(3):332-9. PubMed ID: 20298994 [TBL] [Abstract][Full Text] [Related]
13. Impact of attenuated plaque as detected by intravascular ultrasound on the occurrence of microvascular obstruction after percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction. Shiono Y; Kubo T; Tanaka A; Tanimoto T; Ota S; Ino Y; Aoki H; Ozaki Y; Orii M; Shimamura K; Ishibashi K; Yamano T; Yamaguchi T; Hirata K; Imanishi T; Akasaka T JACC Cardiovasc Interv; 2013 Aug; 6(8):847-53. PubMed ID: 23871509 [TBL] [Abstract][Full Text] [Related]
14. Relation of neutrophil/lymphocyte ratio to coronary flow to in-hospital major adverse cardiac events in patients with ST-elevated myocardial infarction undergoing primary coronary intervention. Akpek M; Kaya MG; Lam YY; Sahin O; Elcik D; Celik T; Ergin A; Gibson CM Am J Cardiol; 2012 Sep; 110(5):621-7. PubMed ID: 22608360 [TBL] [Abstract][Full Text] [Related]
15. Plasma N-terminal fragment of the prohormone B-type natriuretic peptide concentrations in relation to time to treatment and Thrombolysis in Myocardial Infarction (TIMI) flow: a substudy of the Assessment of the Safety and Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention (ASSENT IV-PCI) trial. Jarai R; Huber K; Bogaerts K; Droogne W; Ezekowitz J; Granger CB; Sinnaeve PR; Ross AM; Zeymer U; Armstrong PW; Van de Werf FJ; Am Heart J; 2010 Jan; 159(1):131-40. PubMed ID: 20102879 [TBL] [Abstract][Full Text] [Related]
16. Comparative efficacy of primary angioplasty with stent implantation and thrombolysis in restoring basal coronary artery flow in acute ST segment elevation myocardial infarction: quantitative assessment using the corrected TIMI frame count. Vrachatis AD; Alpert MA; Georgulas VP; Nikas DJ; Petropoulou EN; Lazaros GI; Michelakakis NA; Karavidis AI; Lakoumentas JA; Stergiou L; Zacharoulis AA Angiology; 2001 Mar; 52(3):161-6. PubMed ID: 11269778 [TBL] [Abstract][Full Text] [Related]
17. Twelve-month clinical outcomes of acute non-ST versus ST-segment elevation myocardial infarction patients with reduced preprocedural thrombolysis in myocardial infarction flow undergoing percutaneous coronary intervention. Baek JY; Kang TS; Rha SW; Choi BG; Park SH; Jeong MH Coron Artery Dis; 2018 Aug; 29(5):416-422. PubMed ID: 29708887 [TBL] [Abstract][Full Text] [Related]
18. Elevated plasma asymmetric dimethylarginine level in acute myocardial infarction patients as a predictor of poor prognosis and angiographic impaired reperfusion. Sen N; Ozlu MF; Akgul EO; Kanat S; Cayci T; Turak O; Yaman H; Sokmen E; Ozcan F; Maden O; Demir AD; Covic A; Kanbay M Atherosclerosis; 2011 Nov; 219(1):304-10. PubMed ID: 21726864 [TBL] [Abstract][Full Text] [Related]
19. [Relationship between post-stenting coronary thrombolysis in myocardial infarction flow and plasma von Willebrand factor and ADAMTS-13 levels in patients with ST segment elevation myocardial infarction]. Zhou Q; Li J; Luo XP; Shi HM; Chen H; Zhao BL; Zhu J; Ni HC; Shen W; Wang CP Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Mar; 39(3):212-6. PubMed ID: 21609524 [TBL] [Abstract][Full Text] [Related]
20. Mean platelet volume on admission predicts impaired reperfusion and long-term mortality in acute myocardial infarction treated with primary percutaneous coronary intervention. Huczek Z; Kochman J; Filipiak KJ; Horszczaruk GJ; Grabowski M; Piatkowski R; Wilczynska J; Zielinski A; Meier B; Opolski G J Am Coll Cardiol; 2005 Jul; 46(2):284-90. PubMed ID: 16022956 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]